InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Kelly Timothy P, Executive. Director active across 2 companies, notably Homology Medicines, Inc.. Cumulatively, 7 reports have been logged. Breakdown: 0 buy · 4 sells. Total volume traded: €116k. History available since 1 March 2021. The latest transaction was disclosed on 20 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
37,500 shares0Common StockSEC:0001754067-25-000003:0
3,630 sharesCommon StockSEC:0000899243-22-001747
3,630 sharesCommon StockSEC:0000899243-22-001747:0
6,232 shares@ US$11.162249.7% of flowCommon StockSEC:0000899243-21-035329
6,232 shares@ US$11.162249.7% of flowCommon StockSEC:0000899243-21-035329:0
54 shares@ US$7.700.3% of flowCommon StockSEC:0000899243-21-035330:0
54 shares@ US$7.700.3% of flowCommon StockSEC:0000899243-21-035330
7 of 7 declarations
About Kelly Timothy P
Kelly Timothy P is an Executive at Homology Medicines, Inc. While his specific role is noted as 'See Remarks', he contributes to the leadership and strategy of the company. His expertise is essential for guiding Homology in developing innovative therapeutic solutions.
